Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact
Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact

Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay

April 7, 2021

Exiting new study from our lab suggest that CASP8 may serve as a biomarker for high-risk prostate cancer and potentially renal cancer. Congratulations Laura and team.

https://www.nature.com/articles/s41598-021-87155-5

April 7, 2021

NewsStanford

FacebookXPinterestRedditDeliciousWhatsappEmail
  • PreviousNew review article on the role of Trop2 in prostate cancer

  • NextExciting news: Dr. Manoj Kumar awarded Sanjiv Sam Gambhir – PHILIPS Fellowship in Precision Medicine (PHIND) for “Development of Trop2 Targeted PET-imaging Probe and Therapy for Cancer.” He is a Postdoctoral Research Fellow in Stoyanova Lab.

Related Posts ...

Exciting News: Dr. Tanya Stoyanova receives 2025 Neuroendocrine Tumor Research Foundation Pilot Award

News, UCLA

Exciting News: Dr. Shiqin (Laura) Liu awarded grant from Department of Defense to develop immunotherapy for small-cell lung cancer

News, UCLA

Logo

ADDRESS

Los Angeles
CA 90095, USA
tstoyanova@mednet.ucla.edu

+1 (310) 825 0955

QUICK LINKS

  • UCLA
  • UCLA Health
  • Positions Available
© Stoyanova Lab. All Rights Reserved. | admin login